How can I make an appointment with Oncology FDA Updates?
You can view Oncology FDA Updates's profile on MedSynapse to make an appointment.
What is Oncology FDA Updates's top areas of care?
Oncology FDA Updates's top areas of care are Surgery, Chemotherapy, Radiation Therapy, Targeted Therapy, Immunotherapy, Stem Cell or Bone Marrow Transplant, Hormone Therapy..
Who is Oncology FDA Updates?
Oncology FDA Updates is Oncologist.
Why do patients visit Oncology FDA Updates?
Patients frequently visit Oncology FDA Updates for Surgery, Chemotherapy, Radiation Therapy, Targeted Therapy, Immunotherapy, Stem Cell or Bone Marrow Transplant, Hormone Therapy..

Contributions and Activities

RET fusions have been reported in almost 1-2% of non-small cell lung cancer (NSCLC) cases, and often been associated with higher risk of brain metastasis. These fusions result in constitutively active, ligand-independent signalling and oncogenesis.1,2 Activating RET fusions initiates with other cancer drivers and lead to classic dependency of the t ...

Media
Selpercatinib in RET Fusion–Positive Non–Small-Cell Lung Cancer
1752 Reached1 Comments

Umbralisib approved for marginal zone lymphoma and follicular lymphoma
Umbralisib approved for marginal zone lymphoma and follicular lymphoma
13073 Reached5 Comments2 Likes

Tivozanib Approved for Relapsed or Refractory Advanced Renal Cell Carcinoma
Tivozanib Approved for Relapsed or Refractory Advanced Renal Cell Carcinoma
859 Reached

Empower Your Profile: Ensure Accuracy and Control

Your profile on MedSynapse is a reflection of your professional identity. We understand that information accuracy matters to you. That's why we offer you the power to control it.

  • Correct any inaccuracies.
  • Provide the necessary details for profile verification.
  • Once verified, you can make corrections or delete totally.
Are you doctor Oncology FDA Updates? Take action today to ensure it represents you accurately.
Claim this profile